Development of a model for predicting the severity of chronic obstructive pulmonary disease
- PMID: 36590951
- PMCID: PMC9800610
- DOI: 10.3389/fmed.2022.1073536
Development of a model for predicting the severity of chronic obstructive pulmonary disease
Abstract
Background: Several models have been developed to predict the severity and prognosis of chronic obstructive pulmonary disease (COPD). This study aimed to identify potential predictors and construct a prediction model for COPD severity using biochemical and immunological parameters.
Methods: A total of 6,274 patients with COPD were recruited between July 2010 and July 2018. COPD severity was classified into mild, moderate, severe, and very severe based on the Global Initiative for Chronic Obstructive Lung Disease guidelines. A multivariate logistic regression model was constructed to identify predictors of COPD severity. The predictive ability of the model was assessed by measuring sensitivity, specificity, accuracy, and concordance.
Results: Of 6,274 COPD patients, 2,644, 2,600, and 1,030 had mild/moderate, severe, and very severe disease, respectively. The factors that could distinguish between mild/moderate and severe cases were vascular disorders (OR: 1.44; P < 0.001), high-density lipoprotein (HDL) (OR: 1.83; P < 0.001), plasma fibrinogen (OR: 1.08; P = 0.002), fructosamine (OR: 1.12; P = 0.002), standard bicarbonate concentration (OR: 1.09; P < 0.001), partial pressure of carbon dioxide (OR: 1.09; P < 0.001), age (OR: 0.97; P < 0.001), eosinophil count (OR: 0.66; P = 0.042), lymphocyte ratio (OR: 0.97; P < 0.001), and apolipoprotein A1 (OR: 0.56; P = 0.003). The factors that could distinguish between mild/moderate and very severe cases were vascular disorders (OR: 1.59; P < 0.001), HDL (OR: 2.54; P < 0.001), plasma fibrinogen (OR: 1.10; P = 0.012), fructosamine (OR: 1.18; P = 0.001), partial pressure of oxygen (OR: 1.00; P = 0.007), plasma carbon dioxide concentration (OR: 1.01; P < 0.001), standard bicarbonate concentration (OR: 1.13; P < 0.001), partial pressure of carbon dioxide (OR: 1.16; P < 0.001), age (OR: 0.91; P < 0.001), sex (OR: 0.71; P = 0.010), allergic diseases (OR: 0.51; P = 0.009), eosinophil count (OR: 0.42; P = 0.014), lymphocyte ratio (OR: 0.93; P < 0.001), and apolipoprotein A1 (OR: 0.45; P = 0.005). The prediction model correctly predicted disease severity in 60.17% of patients, and kappa coefficient was 0.35 (95% CI: 0.33-0.37).
Conclusion: This study developed a prediction model for COPD severity based on biochemical and immunological parameters, which should be validated in additional cohorts.
Keywords: biochemical and immunological; chronic obstructive pulmonary disease; prediction model; retrospective study; severity.
Copyright © 2022 Gu, Chen, Qiu, Wang and Chen.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Development and validation of a claims-based prediction model for COPD severity.Respir Med. 2013 Oct;107(10):1568-77. doi: 10.1016/j.rmed.2013.05.012. Epub 2013 Jun 25. Respir Med. 2013. PMID: 23806285
-
Logistic Regression Analysis of Clinical Characteristics for Differentiation of Chronic Obstructive Pulmonary Disease Severity.Emerg Med Int. 2023 Feb 8;2023:5945191. doi: 10.1155/2023/5945191. eCollection 2023. Emerg Med Int. 2023. PMID: 36816328 Free PMC article.
-
Assessing the Efficacy of Modified CT Severity Index Versus Conventional CT Severity Index in Determining Severity and Clinical Outcomes of Chronic Obstructive Pulmonary Disease (COPD).Cureus. 2024 Nov 15;16(11):e73771. doi: 10.7759/cureus.73771. eCollection 2024 Nov. Cureus. 2024. PMID: 39677156 Free PMC article.
-
Pulmonary hypertension in chronic lung diseases.J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D109-16. doi: 10.1016/j.jacc.2013.10.036. J Am Coll Cardiol. 2013. PMID: 24355635 Review.
-
Anti-IL-5 therapies for chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2020 Dec 8;12(12):CD013432. doi: 10.1002/14651858.CD013432.pub2. Cochrane Database Syst Rev. 2020. PMID: 33295032 Free PMC article.
Cited by
-
High density lipoprotein-cholesterol is inversely associated with blood eosinophil counts among asthmatic adults in the USA: NHANES 2011-2018.Front Immunol. 2023 Apr 24;14:1166406. doi: 10.3389/fimmu.2023.1166406. eCollection 2023. Front Immunol. 2023. PMID: 37168867 Free PMC article.
References
-
- Gold. Global strategy for the diagnosis, management and prevention of COPD, global initiative for chronic obstructive lung disease (GOLD). (2019). Available online at: http://goldcopd.org (accessed August 21, 2022).
-
- World Health Organization [WHO]. Projections of mortality and causes of death, 2015 and 2030. Geneva: World Health Organization; (2004).
-
- World Health Organization [WHO]. COPD fact sheet. Geneva: World Health Organization; (2014).
-
- GBD 2015 Chronic Respiratory Disease Collaborators. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the global burden of disease study 2015. Lancet Respir Med. (2017) 5:691–706. - PMC - PubMed
LinkOut - more resources
Full Text Sources